Eszter Vladar
Concepts (286)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cilia | 21 | 2025 | 173 | 3.360 |
Why?
| | Epithelial Cells | 18 | 2025 | 1106 | 2.550 |
Why?
| | Respiratory Mucosa | 13 | 2025 | 322 | 2.330 |
Why?
| | Cystic Fibrosis | 12 | 2025 | 1166 | 1.950 |
Why?
| | Cell Polarity | 8 | 2020 | 137 | 1.930 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 10 | 2025 | 371 | 1.580 |
Why?
| | Wnt Signaling Pathway | 4 | 2023 | 210 | 1.360 |
Why?
| | Trachea | 7 | 2020 | 258 | 1.120 |
Why?
| | Airway Remodeling | 2 | 2025 | 63 | 1.030 |
Why?
| | Aminophenols | 4 | 2025 | 202 | 1.030 |
Why?
| | Benzodioxoles | 2 | 2025 | 159 | 1.000 |
Why?
| | Quinolones | 2 | 2025 | 202 | 0.960 |
Why?
| | Electronic Nicotine Delivery Systems | 2 | 2025 | 108 | 0.890 |
Why?
| | Indoles | 2 | 2025 | 504 | 0.860 |
Why?
| | Asthma | 8 | 2025 | 1774 | 0.860 |
Why?
| | Pyridines | 2 | 2025 | 603 | 0.840 |
Why?
| | Lung | 15 | 2025 | 4089 | 0.820 |
Why?
| | Vaping | 2 | 2025 | 66 | 0.770 |
Why?
| | Organogenesis | 2 | 2019 | 63 | 0.680 |
Why?
| | Centrioles | 5 | 2018 | 47 | 0.660 |
Why?
| | Mucociliary Clearance | 4 | 2025 | 43 | 0.630 |
Why?
| | Mucus | 3 | 2025 | 74 | 0.620 |
Why?
| | Transcriptome | 2 | 2025 | 1036 | 0.600 |
Why?
| | Rhinitis | 4 | 2023 | 169 | 0.590 |
Why?
| | Lung Diseases | 3 | 2022 | 781 | 0.590 |
Why?
| | Olfaction Disorders | 4 | 2024 | 70 | 0.570 |
Why?
| | Sinusitis | 4 | 2023 | 227 | 0.560 |
Why?
| | Cyclin-Dependent Kinase 2 | 1 | 2018 | 35 | 0.550 |
Why?
| | Wnt Proteins | 4 | 2020 | 133 | 0.540 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 919 | 0.490 |
Why?
| | Geminin | 1 | 2016 | 1 | 0.480 |
Why?
| | Movement | 1 | 2018 | 295 | 0.480 |
Why?
| | Morphogenesis | 2 | 2017 | 172 | 0.470 |
Why?
| | Xenopus Proteins | 3 | 2013 | 37 | 0.470 |
Why?
| | Mice | 20 | 2025 | 18261 | 0.470 |
Why?
| | Pyrrolidines | 2 | 2025 | 123 | 0.430 |
Why?
| | Animals | 27 | 2025 | 37948 | 0.420 |
Why?
| | beta Catenin | 3 | 2020 | 252 | 0.400 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2023 | 426 | 0.390 |
Why?
| | Signal Transduction | 8 | 2023 | 5185 | 0.370 |
Why?
| | Pyrazoles | 2 | 2025 | 512 | 0.350 |
Why?
| | Idiopathic Pulmonary Fibrosis | 3 | 2025 | 691 | 0.340 |
Why?
| | Humans | 47 | 2025 | 144667 | 0.320 |
Why?
| | Receptors, Notch | 2 | 2023 | 90 | 0.320 |
Why?
| | Microtubules | 1 | 2012 | 287 | 0.310 |
Why?
| | Developmental Biology | 1 | 2009 | 24 | 0.300 |
Why?
| | Mucins | 3 | 2025 | 75 | 0.300 |
Why?
| | Frizzled Receptors | 3 | 2020 | 25 | 0.290 |
Why?
| | Neovascularization, Pathologic | 2 | 2025 | 284 | 0.290 |
Why?
| | Enterovirus Infections | 2 | 2023 | 173 | 0.280 |
Why?
| | Chloride Channel Agonists | 2 | 2025 | 109 | 0.260 |
Why?
| | Melanocytes | 2 | 2020 | 65 | 0.260 |
Why?
| | Stem Cells | 2 | 2023 | 621 | 0.260 |
Why?
| | Protein Transport | 2 | 2020 | 437 | 0.260 |
Why?
| | Drug Combinations | 2 | 2025 | 393 | 0.260 |
Why?
| | Tumor Suppressor Proteins | 3 | 2020 | 319 | 0.240 |
Why?
| | Phosphoproteins | 1 | 2008 | 339 | 0.240 |
Why?
| | Job Syndrome | 1 | 2025 | 6 | 0.230 |
Why?
| | Phenylpropionates | 1 | 2025 | 27 | 0.230 |
Why?
| | Pulmonary Alveoli | 2 | 2025 | 383 | 0.230 |
Why?
| | Smell | 2 | 2023 | 126 | 0.230 |
Why?
| | Flavoring Agents | 1 | 2025 | 11 | 0.230 |
Why?
| | Oxylipins | 1 | 2025 | 47 | 0.220 |
Why?
| | Epithelium | 2 | 2023 | 310 | 0.220 |
Why?
| | Fucosyltransferases | 1 | 2025 | 33 | 0.220 |
Why?
| | Bronchial Hyperreactivity | 1 | 2025 | 96 | 0.210 |
Why?
| | Cell Cycle Proteins | 2 | 2013 | 628 | 0.210 |
Why?
| | Mice, Transgenic | 5 | 2020 | 2184 | 0.210 |
Why?
| | Cytoskeleton | 2 | 2020 | 197 | 0.210 |
Why?
| | Quinolines | 1 | 2025 | 192 | 0.210 |
Why?
| | Capillaries | 1 | 2025 | 118 | 0.210 |
Why?
| | Drosophila | 2 | 2020 | 167 | 0.210 |
Why?
| | Nicotine | 2 | 2025 | 334 | 0.210 |
Why?
| | Cell Movement | 4 | 2020 | 959 | 0.200 |
Why?
| | Bronchi | 1 | 2025 | 263 | 0.200 |
Why?
| | STAT3 Transcription Factor | 1 | 2025 | 205 | 0.200 |
Why?
| | Mutation | 7 | 2025 | 4081 | 0.200 |
Why?
| | Paranasal Sinuses | 2 | 2023 | 81 | 0.200 |
Why?
| | Mucin 5AC | 4 | 2025 | 70 | 0.200 |
Why?
| | Wnt4 Protein | 1 | 2023 | 20 | 0.200 |
Why?
| | Primary Cell Culture | 2 | 2015 | 172 | 0.200 |
Why?
| | Fluorescent Antibody Technique | 2 | 2015 | 364 | 0.190 |
Why?
| | Cell Differentiation | 5 | 2021 | 2037 | 0.190 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2023 | 76 | 0.190 |
Why?
| | Membrane Proteins | 3 | 2019 | 1159 | 0.180 |
Why?
| | Picornaviridae Infections | 1 | 2023 | 53 | 0.180 |
Why?
| | Pulmonary Surfactants | 1 | 2023 | 103 | 0.180 |
Why?
| | Aryldialkylphosphatase | 1 | 2022 | 17 | 0.180 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2022 | 40 | 0.180 |
Why?
| | Cysts | 1 | 2022 | 112 | 0.170 |
Why?
| | Enoxaparin | 1 | 2022 | 68 | 0.170 |
Why?
| | Pulmonary Fibrosis | 1 | 2025 | 393 | 0.170 |
Why?
| | Interferons | 1 | 2022 | 185 | 0.170 |
Why?
| | Cells, Cultured | 5 | 2025 | 4110 | 0.160 |
Why?
| | Mycobacterium abscessus | 1 | 2022 | 118 | 0.160 |
Why?
| | Skin Neoplasms | 2 | 2020 | 850 | 0.160 |
Why?
| | Bacteriophages | 1 | 2022 | 111 | 0.160 |
Why?
| | Nevus, Epithelioid and Spindle Cell | 1 | 2020 | 14 | 0.150 |
Why?
| | Mice, Knockout | 2 | 2025 | 3109 | 0.150 |
Why?
| | Antiviral Agents | 2 | 2023 | 765 | 0.150 |
Why?
| | Nasal Mucosa | 1 | 2020 | 112 | 0.150 |
Why?
| | Environmental Exposure | 1 | 2024 | 574 | 0.150 |
Why?
| | Immunity, Innate | 1 | 2025 | 843 | 0.150 |
Why?
| | Acute Lung Injury | 1 | 2022 | 301 | 0.150 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5967 | 0.140 |
Why?
| | Chronic Disease | 5 | 2023 | 1810 | 0.140 |
Why?
| | Cyclin A1 | 1 | 2018 | 5 | 0.140 |
Why?
| | Cyclin E | 1 | 2018 | 23 | 0.140 |
Why?
| | Mammary Glands, Animal | 1 | 2019 | 128 | 0.140 |
Why?
| | Cadherins | 1 | 2019 | 200 | 0.130 |
Why?
| | Particulate Matter | 1 | 2020 | 337 | 0.130 |
Why?
| | Microscopy, Electron, Transmission | 2 | 2015 | 154 | 0.130 |
Why?
| | Purines | 1 | 2018 | 187 | 0.130 |
Why?
| | Cell Nucleus | 2 | 2018 | 592 | 0.130 |
Why?
| | Mitosis | 1 | 2018 | 200 | 0.130 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2022 | 368 | 0.130 |
Why?
| | Female | 14 | 2025 | 78304 | 0.120 |
Why?
| | Kidney Tubules | 1 | 2017 | 117 | 0.120 |
Why?
| | Polycystic Kidney Diseases | 1 | 2017 | 71 | 0.120 |
Why?
| | Pneumonia | 1 | 2022 | 629 | 0.120 |
Why?
| | Mucin-5B | 3 | 2025 | 234 | 0.120 |
Why?
| | Nasal Polyps | 1 | 2017 | 59 | 0.120 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1766 | 0.120 |
Why?
| | Xenopus laevis | 3 | 2013 | 105 | 0.120 |
Why?
| | Treatment Outcome | 3 | 2025 | 11735 | 0.110 |
Why?
| | Up-Regulation | 1 | 2018 | 848 | 0.110 |
Why?
| | Nevus, Pigmented | 1 | 2015 | 35 | 0.110 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 590 | 0.110 |
Why?
| | Tissue Fixation | 1 | 2015 | 36 | 0.110 |
Why?
| | Adult | 9 | 2025 | 40489 | 0.110 |
Why?
| | Male | 14 | 2025 | 72431 | 0.110 |
Why?
| | Staining and Labeling | 1 | 2015 | 153 | 0.110 |
Why?
| | Body Patterning | 2 | 2019 | 138 | 0.110 |
Why?
| | Pericytes | 1 | 2014 | 37 | 0.100 |
Why?
| | NIH 3T3 Cells | 2 | 2020 | 147 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-myb | 1 | 2013 | 10 | 0.100 |
Why?
| | Single-Cell Analysis | 3 | 2022 | 357 | 0.100 |
Why?
| | Melanoma | 1 | 2020 | 757 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1467 | 0.100 |
Why?
| | Young Adult | 3 | 2025 | 14122 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2020 | 1319 | 0.090 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 203 | 0.090 |
Why?
| | Microscopy, Electron | 1 | 2013 | 413 | 0.090 |
Why?
| | Embryo, Nonmammalian | 2 | 2012 | 171 | 0.090 |
Why?
| | Cell Line | 2 | 2025 | 2821 | 0.080 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4539 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2015 | 733 | 0.080 |
Why?
| | Models, Biological | 2 | 2009 | 1811 | 0.080 |
Why?
| | Enterovirus | 2 | 2023 | 83 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2019 | 2350 | 0.080 |
Why?
| | Pregnancy | 1 | 2023 | 7122 | 0.080 |
Why?
| | Green Fluorescent Proteins | 2 | 2012 | 407 | 0.080 |
Why?
| | Inflammation | 4 | 2022 | 2870 | 0.080 |
Why?
| | Myoclonic Epilepsies, Progressive | 1 | 2008 | 1 | 0.070 |
Why?
| | Rho Factor | 1 | 2008 | 4 | 0.070 |
Why?
| | Dishevelled Proteins | 1 | 2008 | 4 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2022 | 442 | 0.070 |
Why?
| | Ataxia | 1 | 2008 | 69 | 0.070 |
Why?
| | Obesity | 1 | 2022 | 3070 | 0.070 |
Why?
| | Homozygote | 1 | 2008 | 200 | 0.070 |
Why?
| | Cell Division | 1 | 2009 | 753 | 0.070 |
Why?
| | Lentivirus Infections | 1 | 2007 | 9 | 0.070 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2007 | 44 | 0.070 |
Why?
| | Lentivirus | 1 | 2007 | 61 | 0.060 |
Why?
| | Crosses, Genetic | 1 | 2007 | 124 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2019 | 339 | 0.060 |
Why?
| | Mice, Inbred C3H | 1 | 2007 | 252 | 0.060 |
Why?
| | Transduction, Genetic | 1 | 2007 | 131 | 0.060 |
Why?
| | Models, Genetic | 1 | 2009 | 531 | 0.060 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 231 | 0.060 |
Why?
| | Proteins | 1 | 2012 | 1016 | 0.060 |
Why?
| | Actins | 1 | 2008 | 421 | 0.060 |
Why?
| | Gene Knockdown Techniques | 2 | 2019 | 334 | 0.060 |
Why?
| | Quality of Life | 3 | 2023 | 3183 | 0.060 |
Why?
| | Endothelial Progenitor Cells | 1 | 2025 | 20 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2022 | 743 | 0.060 |
Why?
| | Glycosylation | 1 | 2025 | 161 | 0.050 |
Why?
| | Middle Aged | 7 | 2024 | 35971 | 0.050 |
Why?
| | Machine Learning | 2 | 2020 | 587 | 0.050 |
Why?
| | Follow-Up Studies | 2 | 2024 | 5414 | 0.050 |
Why?
| | Mutagens | 1 | 2004 | 27 | 0.050 |
Why?
| | Genetic Techniques | 1 | 2004 | 67 | 0.050 |
Why?
| | Microvessels | 1 | 2025 | 98 | 0.050 |
Why?
| | Sputum | 1 | 2025 | 308 | 0.050 |
Why?
| | Phosphofructokinase-2 | 1 | 2022 | 16 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1948 | 0.050 |
Why?
| | Rhinovirus | 1 | 2023 | 60 | 0.050 |
Why?
| | Quercetin | 1 | 2022 | 19 | 0.050 |
Why?
| | Drosophila melanogaster | 1 | 2004 | 237 | 0.040 |
Why?
| | Serine Endopeptidases | 1 | 2022 | 129 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 130 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 197 | 0.040 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 437 | 0.040 |
Why?
| | Bleomycin | 1 | 2022 | 253 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 2754 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 294 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2022 | 227 | 0.040 |
Why?
| | Amino Acid Sequence | 3 | 2012 | 2136 | 0.040 |
Why?
| | Alleles | 2 | 2019 | 886 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2022 | 334 | 0.040 |
Why?
| | Comparative Genomic Hybridization | 1 | 2020 | 28 | 0.040 |
Why?
| | Molecular Sequence Data | 3 | 2012 | 2909 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 117 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2020 | 122 | 0.040 |
Why?
| | Antibodies, Neutralizing | 1 | 2022 | 341 | 0.040 |
Why?
| | Smokers | 1 | 2020 | 137 | 0.040 |
Why?
| | Cadherin Related Proteins | 1 | 2019 | 12 | 0.040 |
Why?
| | Fibroblasts | 1 | 2025 | 1019 | 0.040 |
Why?
| | Loss of Function Mutation | 1 | 2019 | 46 | 0.040 |
Why?
| | Prospective Studies | 2 | 2022 | 7994 | 0.040 |
Why?
| | Child | 4 | 2020 | 22600 | 0.030 |
Why?
| | Embryonic Development | 1 | 2019 | 123 | 0.030 |
Why?
| | Health Status | 1 | 2023 | 834 | 0.030 |
Why?
| | Lipids | 1 | 2023 | 706 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2012 | 393 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 319 | 0.030 |
Why?
| | Turbinates | 1 | 2017 | 14 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2022 | 496 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2019 | 338 | 0.030 |
Why?
| | Computer Systems | 1 | 2017 | 55 | 0.030 |
Why?
| | Air Pollution | 1 | 2020 | 318 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2025 | 2591 | 0.030 |
Why?
| | Aged | 3 | 2024 | 25955 | 0.030 |
Why?
| | Air Pollutants | 1 | 2020 | 430 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1501 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1338 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2017 | 751 | 0.030 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2014 | 21 | 0.030 |
Why?
| | Magnetics | 1 | 2014 | 47 | 0.030 |
Why?
| | Child, Preschool | 2 | 2020 | 11790 | 0.030 |
Why?
| | Adolescent | 3 | 2020 | 22409 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2117 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 503 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2014 | 245 | 0.030 |
Why?
| | Microcirculation | 1 | 2014 | 141 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1847 | 0.030 |
Why?
| | Ependyma | 1 | 2013 | 2 | 0.030 |
Why?
| | Mice, SCID | 1 | 2014 | 368 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2020 | 1374 | 0.020 |
Why?
| | Xenopus | 1 | 2013 | 89 | 0.020 |
Why?
| | Time Factors | 1 | 2024 | 7140 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2020 | 2489 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 631 | 0.020 |
Why?
| | Transcription Factors | 1 | 2020 | 1726 | 0.020 |
Why?
| | Algorithms | 1 | 2020 | 1844 | 0.020 |
Why?
| | Muscle Proteins | 1 | 2013 | 240 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2137 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2012 | 318 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1928 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2012 | 245 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2019 | 2815 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3147 | 0.020 |
Why?
| | Biomarkers | 1 | 2022 | 4261 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2014 | 886 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2012 | 407 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 973 | 0.020 |
Why?
| | Aging | 1 | 2020 | 1938 | 0.020 |
Why?
| | Cytokines | 1 | 2017 | 2045 | 0.020 |
Why?
| | Physical Chromosome Mapping | 1 | 2008 | 20 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3414 | 0.020 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2008 | 21 | 0.020 |
Why?
| | LIM Domain Proteins | 1 | 2008 | 20 | 0.020 |
Why?
| | Consanguinity | 1 | 2008 | 49 | 0.020 |
Why?
| | Genes, Recessive | 1 | 2008 | 78 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2014 | 864 | 0.020 |
Why?
| | Microsatellite Repeats | 1 | 2008 | 155 | 0.020 |
Why?
| | Genetic Markers | 1 | 2008 | 332 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 379 | 0.020 |
Why?
| | Pedigree | 1 | 2008 | 515 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 8284 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 495 | 0.020 |
Why?
| | Skin | 1 | 2012 | 762 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 906 | 0.020 |
Why?
| | Nondisjunction, Genetic | 1 | 2004 | 5 | 0.010 |
Why?
| | Methyl Methanesulfonate | 1 | 2004 | 7 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 2004 | 72 | 0.010 |
Why?
| | Mechlorethamine | 1 | 2004 | 52 | 0.010 |
Why?
| | Kidney | 1 | 2012 | 1495 | 0.010 |
Why?
| | Meiosis | 1 | 2004 | 101 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2004 | 205 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2004 | 507 | 0.010 |
Why?
| | DNA Repair | 1 | 2004 | 256 | 0.010 |
Why?
| | Brain | 1 | 2013 | 2934 | 0.010 |
Why?
| | Base Sequence | 1 | 2004 | 2177 | 0.010 |
Why?
| | Saccharomyces cerevisiae | 1 | 2004 | 579 | 0.010 |
Why?
| | DNA | 1 | 2004 | 1447 | 0.010 |
Why?
|
|
Vladar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|